Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-012121

President & CEO sold 11,495 shares at $22.37 ($257,143)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
ROBIN HOWARD W President & CEO 2021-02-16 Sale −11,495 $22.37 $257,143 447,198 D
Open-market sales · 11,495 sh · avg $22.37 · $257,143
Loading xslF345X03/doc4.xml…